In the meantime, the ROS production was rescued and the ratio of GSH/GSSG was decreased, further confirming that ERRα knockdown modulates the mitochondrial metabolic adaption to make resistant breast cancer cells re-sensitive to lapatinib. Here, ESRRA is linked to breast cancer.